Your browser doesn't support javascript.
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.
Huemer, Florian; Rinnerthaler, Gabriel; Jörg, Benedikt; Morre, Patrick; Stegbuchner, Birgit; Proksch, Elisabeth; Fleimisch, Stefanie; Oberkofler, Hannes; Kremser, Iris; Greil, Richard; Egle, Alexander.
  • Huemer F; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzbur
  • Rinnerthaler G; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzbur
  • Jörg B; Cancer Cluster Salzburg, 5020, Salzburg, Austria.
  • Morre P; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzbur
  • Stegbuchner B; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzbur
  • Proksch E; Department of Geriatric Medicine, Christian-Doppler-Klinik, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
  • Fleimisch S; Department of Geriatric Medicine, Christian-Doppler-Klinik, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
  • Oberkofler H; Department of Pneumology, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
  • Kremser I; Department of Laboratory Medicine, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
  • Greil R; Department of Laboratory Medicine, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria.
  • Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzbur
Geroscience ; 43(4): 1877-1897, 2021 08.
Article in English | MEDLINE | ID: covidwho-1173978
ABSTRACT
COVID-19-associated case fatality rates up to 48% were reported among nursing facility residents. During the first wave of the COVID-19 pandemic, routine SARS-CoV-2 testing in long-term care facilities in the Province of Salzburg and centralized hospitalization in the COVID-19 unit of the Paracelsus Medical University Salzburg (Austria) irrespective of symptoms was implemented. Baseline characteristics and the course of COVID-19 disease were assessed among hospitalized long-term care facility residents within the COVID-19 Registry of the Austrian Group Medical Tumor Therapy (AGMT; NCT04351529). Between the 24th of March and the 20th of April 2020, 50 COVID-19-positive residents were hospitalized. The median age was 84.5 years (range 79-88) and the median number of comorbidities and baseline medication classes was 6 (IQR 4-7) and 5 (IQR 3-6), respectively. At admission, 31 residents (62%) were symptomatic, nine residents (18%) pre-symptomatic whereas ten residents (20%) remained asymptomatic. The 30-day mortality rate from hospitalization was 32% and significantly higher in symptomatic residents at admission when compared to asymptomatic residents including pre-symptomatic residents (48% [95% CI 27-63%] versus 5% [95% CI 0-15%], p=0.006). The Early Warning Score (EWS) at admission was associated with 30-day mortality high risk 100%, intermediate risk 50% (95% CI 0-78%), and low risk 21% (95% CI 7-32%) (p<0.001). In light of comparably low mortality rates between asymptomatic and pre-symptomatic hospitalized COVID-19-positive residents, we suggest the supply of comparable intensity and quality of monitoring and care in long-term care facilities as an alternative to immediate hospitalization upon a positive COVID-19 test in asymptomatic residents.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Geroscience Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Geroscience Year: 2021 Document Type: Article